Medicure (MCUJF) EBITDA Margin Growth (5y) (2014 - 2026)
Medicure (MCUJF) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,728.00 |
| Dec 31, 2025 | 18,915.00 |
| Sep 30, 2025 | 3,169.00 |
| Jun 30, 2025 | 8,395.00 |
| Mar 31, 2025 | -563.00 |
| Dec 31, 2024 | 11,916.00 |
| Sep 30, 2024 | 194.00 |
| Jun 30, 2024 | -520.00 |
| Mar 31, 2024 | -4,003.00 |
| Dec 31, 2023 | 3,704.00 |
| Sep 30, 2023 | -207.00 |
| Jun 30, 2023 | -71.00 |
| Mar 31, 2023 | 8,572.00 |
| Dec 31, 2022 | -9,331.00 |
| Sep 30, 2022 | -1,886.00 |
| Jun 30, 2022 | -2,312.00 |
| Dec 31, 2021 | -2,461.00 |
| Sep 30, 2021 | -4,484.00 |
| Jun 30, 2021 | -2,652.00 |
| Mar 31, 2021 | 1,722.00 |